NEW YORK (GenomeWeb News) – Kinaxo Biotechnologies said today that it will collaborate with Roche Diagnostics to support Roche’s development of new targeted treatment-related technologies.

Under the agreement, which is the second collaboration between the companies, Kinaxo will use its PhosphoScout phosphoproteomics technology to support targeted treatment development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.